These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. The effect of clobetasone butyrate and other topical steroids on skin thickness of the domestic pig. Winter GD; Wilson L Br J Dermatol; 1976 May; 94(5):545-50. PubMed ID: 1268065 [TBL] [Abstract][Full Text] [Related]
27. Bioassay system for formulations of topically applied glucocorticosteroids. Stoughton RB Arch Dermatol; 1972 Dec; 106(6):825-7. PubMed ID: 4639246 [No Abstract] [Full Text] [Related]
28. [TREATMENT OF PSORIASIS WITH WET OCCLUSIVE DRESSING]. KONIA H Dermatologica; 1964; 129():47-56. PubMed ID: 14181377 [No Abstract] [Full Text] [Related]
29. Bio-assay of corticosteroids for topical application. Spearman RI; Jarrett A Br J Dermatol; 1975 May; 92(5):581-4. PubMed ID: 1174471 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of a new corticosteroid, fluocinonide, in a scientifically designed base. Burdick KH Acta Derm Venereol Suppl (Stockh); 1971 May; 52(67):24-31. PubMed ID: 5291631 [No Abstract] [Full Text] [Related]
31. Desonide, a potent nonfluorinated topical steroid, vasoconstriction assay and clinical trial. Smith EB; Gregory JF; Bartruff JK South Med J; 1973 Mar; 66(3):325-9. PubMed ID: 4570656 [No Abstract] [Full Text] [Related]
32. Tachyphylaxis to the action of topically applied corticosteroids. du Vivier A; Stoughton RB Arch Dermatol; 1975 May; 111(5):581-3. PubMed ID: 1130802 [TBL] [Abstract][Full Text] [Related]
33. An improved method of assessing topical corticosteroid activity. Barnes H; Gaylarde PM; Brock AP; Sarkany I Br J Dermatol; 1975 Oct; 93(4):459-64. PubMed ID: 1201192 [TBL] [Abstract][Full Text] [Related]
35. [Corticosteroid effect and vasoconstriction. 1. Suppression of corticosteroid-induced vasoconstriction in the healthy skin by tolazoline]. Brehm K; Maucher OM Arzneimittelforschung; 1972 Jun; 22(6):1038-9. PubMed ID: 5068352 [No Abstract] [Full Text] [Related]
36. Percutaneous corticosteroid absorption correlated to partition coefficient. Katz M; Shaikh ZI J Pharm Sci; 1965 Apr; 54(4):591-4. PubMed ID: 5842347 [No Abstract] [Full Text] [Related]
37. A COMPARISON OF FLUOCINOLONE AND TRIAMCINOLONE ACETONIDES. CHALMERS D; MORLEY WN Br J Dermatol; 1963 Jul; 75():278-9. PubMed ID: 14046147 [No Abstract] [Full Text] [Related]
38. The absorption of topical corticosteroids, with particular reference to percutaneous absorption in infancy and childhood. Keipert JA Med J Aust; 1971 May; 1(19):1021-5. PubMed ID: 4930660 [No Abstract] [Full Text] [Related]
39. The effect of constituents in white soft paraffin on the efficacy of corticosteroid ointments in the vasoconstrictor test. Coldman MF; Lockerbie L J Pharm Pharmacol; 1971 Dec; 23():253S-254S. PubMed ID: 4401514 [No Abstract] [Full Text] [Related]
40. Paired comparison vasoconstrictor assays. A comparison of methods for the determination of relative vasoconstrictor potency of topically applied corticosteroids. Poulsen BJ; Burdick K; Bessler S Arch Dermatol; 1974 Mar; 109(3):367-71. PubMed ID: 4814938 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]